About The Webinar
Whilst a reasonable number of licensed preparations are available for the treatment of heart failure in dogs; there are only 2 licensed products (furosemide and diltiazem) available for cats with heart disease. As a result the clinician is frequently faced with cases where they have exhausted licensed preparation of there are no suitable licensed drugs for treating the patient’s problem.
The focus of this webinar will be on the rational and cost effective use of drugs in the management of congestive heart failure and arrhythmias in cats and dogs based on the current best evidence. Licensed and the most widely used non-licensed preparations will be discussed in detail along with suggested drug combinations, changing, monitoring and withdrawing therapies.